Sylvant
Active substance: siltuximab
INJECTION, POWDER, FOR SOLUTION · SILTUXIMAB 100 mg/1
United StatesActive
Marketing holder: Recordati Rare Diseases, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SILTUXIMAB · 100 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12097-4edd-7f6e-a0f3-584fec3ef4a1,01a12099-dd8e-7b39-8692-b368f8fb4de9;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73090-420
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 73090-420 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73090-420 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73090-420 · Verified 2026-10-09 · open in source